Objectives
The aim of this hospital-based prospective study was to evaluate the diagnostic ability of breast cancer screening in Korean middle-aged women using age, ultrasonography, mammography, and magnification mammography, which are commonly used in most hospitals. Methods
A total of 21 patents were examined using ultrasonography, mammography, and magnification mammography, and their data were prospectively analyzed from August 2011 to March 2013. All patients were divided into benign and malignant groups and the screening results were classified using the American College of Radiology Breast Imaging Reporting and Data System (BI-RADS). The final pathology report was used as the reference standard and the sensitivity and specificity of ultrasonography, mammography, and magnification mammography were evaluated using receiver-operating characteristics (ROC) analysis. Results
The analysis included 21 patients who underwent biopsy. Among them, three (14.3%) were positive and 18 (85.7%) negative for breast cancer. The average age was 50.5 years (range = 38–61 years). The sensitivity was the same for ultrasonography and magnification mammography and the specificity of magnification mammography was higher than that of ultrasonography. The highest area under the ROC curve (AUC) was observed in the combination of age and magnification mammography (1.000) and the decreasing order of AUC in others was magnification mammography (0.833), ultrasonography (0.787), mammography (0.667), and age (0.648). Conclusions
In Korean women, the diagnostic accuracy of magnification mammography was better than that of ultrasonography and mammography. The combination of age and magnification mammography increased the sensitivity and diagnostic accuracy.
Citations
Citations to this article as recorded by
Breast cancer in India: Present scenario and the challenges ahead Ravi Mehrotra, Kavita Yadav World Journal of Clinical Oncology.2022; 13(3): 209. CrossRef
Integrating age, BMI, and serum N-glycans detected by MALDI mass spectrometry to classify suspicious mammogram findings as benign lesions or breast cancer Calvin R. K. Blaschke, Elizabeth G. Hill, Anand S. Mehta, Peggi M. Angel, Christine Laronga, Richard R. Drake Scientific Reports.2022;[Epub] CrossRef
Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy Sae Byul Lee, Shambhunath Bose, Sei Hyun Ahn, Byung Ho Son, Beom Seok Ko, Hee Jeong Kim, Il Yong Chung, Jisun Kim, Woochang Lee, Myung-Su Ko, Kyungsoo Lee, Suhwan Chang, Hyoung Soon Park, Jong Won Lee, Dong-Chan Kim, Anna Halama PLOS ONE.2020; 15(4): e0231004. CrossRef
Recommendations for screening and early detection of common cancers in India Preetha Rajaraman, Benjamin O Anderson, Partha Basu, Jerome L Belinson, Anil D' Cruz, Preet K Dhillon, Prakash Gupta, Tenkasi S Jawahar, Niranjan Joshi, Uma Kailash, Sharon Kapambwe, Vishwa Mohan Katoch, Suneeta Krishnan, Dharitri Panda, R Sankaranarayana The Lancet Oncology.2015; 16(7): e352. CrossRef
Predicting 5-Year Survival Status of Patients with Breast Cancer based on Supervised Wavelet Method Maryam Farhadian, Hossein Mahjub, Jalal Poorolajal, Abbas Moghimbeigi, Muharram Mansoorizadeh Osong Public Health and Research Perspectives.2014; 5(6): 324. CrossRef